Post-translational modifications of proteins are major regulatory events in many cellular processes such as cell proliferation, differentiation, and cell death. In particular, protein phosphorylation is a major mode of post-translational modifications and an important regulatory event for many cellular processes by modulating intracellular signaling pathways (Hunter, [@B1]). It has been reported that phosphorylated proteins are subsequently subjected to a new type of"post-phosphorylation" regulation by a peptidylprolyl isomerase Pin1. Pin1 is a peptidylprolyl *cis--trans* isomerase and only binds to serine or threonine residue immediately preceding a proline residue (Ser/Thr-Pro). After binding to the motif, Pin1 dynamically changes the conformation of target proteins via *cis--trans* isomerization of the peptide bonds. Such conformational changes have profound effects on the function of substrate proteins by modulating their catalytic activity, protein--protein interaction, sub-cellular localization, and protein stability (Ryo et al., [@B8]; Lu et al., [@B3]). With the diverse physiological roles of Pin1, it has been shown that Pin1 is linked to the etiology of several diseases that include cancers, Alzheimer\'s disease and immune diseases (Lu and Zhou, [@B4]). In addition to this, recent studies demonstrate that the stability and function of several viral proteins are also regulated by phosphorylation-dependent Pin1-mediated prolyl-isomerization (Figure [1](#F1){ref-type="fig"}).

![**A novel post-phosphorylation regulatory mechanism for viral protein stability**. The phosphorylation of viral proteins (HBV HBx, HTLV-1 Tax, and HIV IN) by the proline-directed kinases (JNK, MAPK etc.) generates binding modules for Pin1. Subsequent prolyl-isomerization by Pin1 induces conformational changes and thereby enhances the viral protein stability.](fmicb-01-00107-g001){#F1}

Pang et al. ([@B6]) firstly identified Pin1 as a novel binding partner for the hepatitis B virus X protein (HBx), a viral encoding oncoprotein. The interaction appears to have significant effects on the stability and pro-tumorigenic activity of the viral protein (Pang et al., [@B6]). Pin1 overexpression was found to be related to HBx expression in HBV-related tumors. Pang et al. ([@B6]) confirmed that Pin1 binds HBx at the specific phosphorylated the Ser41-Pro motif. This interaction was shown to be inhibited by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK) inhibitor, suggesting the possible role of mitogen-activated kinase (MAPK) family in the phosphorylation of the Ser41-Pro motif. Pin1 overexpression was shown to increase the protein stability of HBx as well as HBx-mediated transactivation. Concomitant expression of Pin1 and HBx in the non-tumorigenic human hepatocyte cell line MIHA led to a synergistic increase in tumor growth. Moreover, in hepatocellular carcinoma Hep3B cells with suppressed Pin1 expression, HBx-mediated tumor growth in nude mice was abrogated. These results together indicate that Pin1 enhance hepatocarcinogenesis in HBV-infected hepatocytes by activating both stability and function of HBx.

The second target for Pin1--viral protein interaction is HTLV-1 Tax. Two groups have reported the functional interaction between HTLV-1 Tax oncoprotein and Pin1 (Jeong et al., [@B2]; Peloponese Jr. et al., [@B7]). Pin1 is highly expressed in adult T cell leukemia (ATL) cells expressing Tax protein and forced expression of Pin1 in turn increases the Tax protein expression. Pin1 prolonged the protein stability of Tax by suppressing the ubiquitination and subsequent lysosomal degradation of Tax. Pin1 interacts with phosphorylated Tax on its Ser160-Pro motif. On the other hand, a Pin1 inhibitor Juglone suppressed cell proliferation of the Tax-expressing T cell line. Thus, Pin1 plays a supporting role in Tax-mediated cell transformation in the post-translational regulation of Tax. The targeting of Pin1 may offer a new insight into the pathogenesis of HTLV-1 related diseases such as ATL.

A recent study has demonstrated that HIV integrase (IN) is a new target for Pin1. Indeed, the protein stability HIV IN was found to be regulated by phosphorylation-dependent Pin1-catalyzed prolyl-isomerization (Manganaro et al., [@B5]). Exogenously transfected HIV IN can associate with Pin1. Furthermore, such interaction is dependent on phosphorylation of HIV IN, specifically on the Ser57-Pro motif, which can be phosphorylated by host kinase c-Jun N-terminal kinase (JNK). Importantly, this interaction has indeed profound functional significance. HIV IN is a protein with a short half-life, but its steady-state levels were shown to significantly increase during Pin1 interaction. In addition to regulating protein stability, Pin1 can concomitantly enhance the activity for HIV IN thereby facilitating the HIV-1 proviral integration into the host cell genome. These concerted activities of Pin1-dependent prolyl-isomerization can in turn lead to efficient HIV-1 replication. Since the lack of these modifications restricts viral infection, Pin1 could be an intriguing target for anti-HIV therapy.

In conclusion, these observations are of special relevance to Pin1 for the natural course of viral replication via modulating the stability and function of viral proteins. Because it is quite likely that other viral proteins in different viral species could also be Pin1 targets, future studies for Pin1--viral protein interaction would shed new light on molecular etiology of virus--host cell interaction. Furthermore, these studies may also have therapeutic implications of Pin1 inhibition in viral infection. With specific Pin1 inhibitors being developed, the application of such molecules in combination with current antiviral therapies could change the course of viral replication and prevent the development of viral pathogenicities.
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